Delivery Order SPE2DB20D2104-SPE2DB25FMDAN

Award Date 11/27/24
Potential Completion Date 11/29/24
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Forteo 600 mcg/2.4 ml pen injector. The delivery order, valued at $10,494.33, is a firm-fixed-price contract with a completion date of September 23, 2024. AmerisourceBergen, through its Corporate Office division, will provide this critical medication to support military treatment facilities and other federal healthcare...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Forteo 600 mcg/2.4 ml pen injections. The $10,678.08 firm fixed-price contract has a completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $12,384.01, is a Firm Fixed Price Delivery Order contract for the procurement of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a pharmaceutical product. The contract has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract worth $6,027.24 for the supply of Forteo 600 mcg/2.4 mL pen injections. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,772.06 firm fixed price delivery order is for the supply of Forteo 600 mcg/2.4 ml pen injections. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML to support federal healthcare programs. The $10,949.92 Firm Fixed Price contract has an ultimate completion date of November 15, 2024 and was awarded by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,772.06 firm fixed-price delivery order is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialized medication. The contract has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,833.32, is a Firm Fixed Price Delivery Order for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Forteo 600 mcg/2.4 ml pen injections. The $3,544.12 firm fixed price delivery order has a completion date of May 19, 2023 and is not associated with any set-aside requirements. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the delivery of 600 mcg/2.4 ml Forteo (teriparatide) pen injections to support military healthcare programs. The delivery order is valued at $3,666.64 and has a firm fixed price. The contract has an ultimate completion date of January 17, 2025....
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMDAN
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 600 mcg/2.4 ml Forteo Pen Injections. The $27,448.06 firm fixed-price contract has a completion date of November 29, 2024 and is not designated as a set-aside.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely one of many delivery orders issued against that IDC to fulfill the DLA's pharmaceutical procurement requirements.

Generated 5/20/25, 1:44 PM